Jack Goldstein, Director at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), bought 1,000 shares at $14.38 ($14K) on 2012-08-15, disclosed to the SEC on 2012-08-16.
Open-market purchase of $14k OGXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ILMN | SELL | 2010-03-17 | $403K | — | Filing → |
| ILMN | SELL | 2010-03-10 | $577K | — | Filing → |
| ILMN | SELL | 2010-03-03 | $546K | — | Filing → |